Nanostructured lipid carriers as delivery system for the phospholipase A2 inhibitors PX-18 and PX-13 for dermal application

PX-18 and PX-13 are secretory phospholipase A2 -IIA (sPLA2 -IIA) inhibitors. An increased expression of sPLA2 in psoriatic skin has been reported. The selective inhibition of this enzyme is a new therapeutic approach. For dermal application PX-18 and PX-13 have been loaded to Nanostructured lipid carriers (NLC). The PX-18-loaded and PX-13-loaded NLC possessed an average particles size of about 250 nm, a narrow particle size distribution (PI < 0.2), a high entrapment efficiency as well as a good physical stability, as already indicated by their high zeta potential. Both NLC formulations have been incorporated into a hydroxyethyl cellulose gel and an o/w cream. In the gel and in the o/w cream PX-18-loaded and PX-13loaded NLC showed a good physical stability. Neither aggregation nor dissolution of NLC took place.